Abeona Therapeutics Inc (ABEO)

Cost of Revenue

$4.18M

Quarterly · Period ending: · USD

ABEO logo

ABEO Cost of Revenue

Latest reported$4.18M
ABEO Quarterly Cost of Revenue ($0.00 → $4.18M)
High-resolution chart · PNG

ABEO cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abeona Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
4,177,000
3,565,000
2,837,000
488,000
100,000
0
776,000
0
0
0
721,000
30,000
1,575,000
0
6,372,000
0
7,008,000
10,545,000
12,803,000
0
0
0
0
7,969,000
0
6,818,000
9,605,000
10,917,000
2,057,000
11,737,000
9,470,000
13,150,000
7,916,000
8,162,000
5,706,000
3,277,000
5,808,000
2,198,000
0
0
0
0
0
0
0
0
0
0
0
0
124,875,000
7,000
53,000
65,000
66,000
79,000
63,000
59,000
404,000
61,000
266,000
92,000
140,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
403,000
123,000
178,000
102,000
142,000
40,000
31,000
26,000
34,000
30,000
104,000
109,000
107,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.